HCV genotype 5: Epidemiology and spread of an uncommon genotype

Journal of Clinical Virology

Volumn 41, Issue 2, 2008, Pages 170-171

  Verbeeck, Jannick ^a   Peigue Lafeuille, Hélène ^b,c   Ross, R Stefan ^d   Abergel, Armand ^e   Nevens, Frederik ^f   Van der Merwe, Schalk ^g   Van Ranst, Marc ^a   Henquell, Cécile ^c  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^b UNIVERSITÉ CLERMONT AUVERGNE   (France)

^c SERVICE DE RHUMATOLOGIE   (France)

^d UNIVERSITY HOSPITAL ESSEN   (Germany)

^e HÔTEL DIEU   (France)

^f UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^g Institute of Pathology   (South Africa)

Author keywords

Epidemiology; Genotype 5; HCV; Hepatitis C virus; Phylogenetic analysis; Treatment response

Indexed keywords

PEGINTERFERON; RIBAVIRIN;

ARTICLE; CLINICAL FEATURE; DEMOGRAPHY; DRUG EFFICACY; GENETIC VARIABILITY; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; NONHUMAN; PRIORITY JOURNAL; VIRUS TRANSMISSION;

EID: 38749144335     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2007.11.004     Document Type: Note

References (11)

1. Bonny C., Roche C., Randl K., Ughetto S., Henquell C., Martineau N., et al. Treatment of interferon-naïve patients with HCV genotype 5 with interferon (or peginterferon) plus ribavirine results in a very high sustained viral response. Hepatology 38 (2003) A75
2. Davidson F., Simmonds P., Ferguson J.C., Jarvis L.M., Dow B.C., Follett E.A.C., et al. Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 5' non-coding region. J Gen Virol 76 (1995) 1197-1204
3. Henquell C., Cartau C., Abergel A., Lauricesse H., Regagnon C., De Champs C., et al. High prevalence of hepatitis C virus type 5 in Central France evidenced by a prospective study from 1996 to 2002. J Clin Microbiol 42 (2004) 3030-3035
4. Jover R., Pérez-Serra J., de Vera F., Alamo J.M., Munoz C., Yago C., et al. Infection by genotype 5a of HCV in a district of Southeast Spain. Am J Gastroenterol 96 (2001) 3042
5. Legrand-Abravanel F., Sandrès-Saune K., Barange K., Alric L., Moreau J., Desmorat P., et al. Hepatitis C virus genotype 5: epidemiological characteristics and sensitivity to combination therapy with interferon-α plus ribavirine. J Infect Dis 189 (2004) 1397-1400
6. Levi J.E., Takaoka D.T., Garrini R.H., Fachini R.M., Focaccia R., de Bortholi Santos E., et al. Three cases of infection with hepatitis C virus genotype 5 among Brazilian hepatitis patients. J Clin Microbiol 40 (2002) 2645-2647
7. Murphy D., Willems B., and Delage G. Use of the 5' noncoding region for genotyping hepatitis C virus. J Infect Dis 169 (1994) 473-475
8. Pybus O.G., Charleston M.A., Gupta S., Rambaut A., Holmes E.C., and Harvey P.E. The epidemic behaviour of the hepatitis C virus. Science 292 (2001) 2323-2325
9. Ross R.S., Viazov S., Renzing-Köhler K., and Roggendorf M. Changes in the epidemiology of hepatitis C infection in Germany: shift in the predominance of hepatitis C subtypes. J Med Virol 60 (2000) 122-125
10. Simmonds P., Buck J., Combet C., Deleage G., Enomoto N., Feinstone S., et al. Consensus proposal for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 42 (2005) 962-973
11. Verbeeck J., Maes P., Lemey P., Pybus O.G., Wollants E., Song E., et al. Investigating the origin and spread of hepatitis C virus genotype 5a. J Virol 50 (2006) 4220-4226